Skip to main content
. 2021 Jan 20;13(3):372. doi: 10.3390/cancers13030372

Table 1.

Statistical value of AUC;measured intensity of c-Met protein, treating c-Met inhibitors and CDK4/6 inhibitors.

Target Drug Name Diff. (%) p-Value Summary 1
c-Met Ab SAIT301 −37 0.0004 ***
c-Met Inhibitor Carbozantinib −44.6 <0.0001 ****
Crizotinib −36.3 0.0007 ***
Fretinib −47.7 <0.0001 ****
Capmatinib −49 <0.0001 ****
CDK4/6 Inhibitor Abemaciclib −31.9 0.0035 **
Palbociclib 10.7 0.7588 ns 2
Ribociclib 34.1 0.0016 ns

1 0.01 ≥ ** > 0.001 ≥ *** > 0.0001 ≥ ****. 2 ns; not significant.